These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8304728)

  • 1. Reduced bioavailability of cyclosporin A capsules in a renal transplant patient with partial gastrectomy and ileal resection.
    Tewari A; Ward RG; Sells RA; Roberts NB
    Ann Clin Biochem; 1993 Nov; 30 ( Pt 6)():587-9. PubMed ID: 8304728
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of pharmacokinetics between CsA capsules and Sandimmun Neoral in pediatric patients.
    Lin CY; Lee SF
    Transplant Proc; 1994 Oct; 26(5):2973-4. PubMed ID: 7940938
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioavailability and patient acceptance of cyclosporine soft gelatin capsules in renal allograft recipients.
    Min DI; Hwang GC; Bergstrom S; Madras PN; Shaffer D; Sahyoun AI; Monaco AP
    Ann Pharmacother; 1992 Feb; 26(2):175-9. PubMed ID: 1554925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microemulsion technology in the reformulation of cyclosporine: the reason behind the pharmacokinetic properties of Neoral.
    Ritschel WA
    Clin Transplant; 1996 Aug; 10(4):364-73. PubMed ID: 8884110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between cyclosporine bioavailability and clinical outcome in renal transplant recipients.
    Schroeder TJ; Hariharan S; First MR
    Transplant Proc; 1994 Oct; 26(5):2787-90. PubMed ID: 7940878
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of oral cyclosporine in children awaiting renal transplantation.
    Gusmano R; Verrina E; Piaggio G; Corbetta G; Basile GC; Perfumo F
    Transplant Proc; 1994 Oct; 26(5):2781-3. PubMed ID: 7940877
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug interaction in a renal transplant patient: cyclosporin-Neoral and orlistat.
    Evans S; Michael R; Wells H; Maclean D; Gordon I; Taylor J; Goldsmith D
    Am J Kidney Dis; 2003 Feb; 41(2):493-6. PubMed ID: 12552515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diet and cyclosporin A--pharmacokinetic comparison between Neoral and Sandimmune gelatin capsules.
    Browne BJ; Jordan S; Welsh MS; Van Buren C; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):2959-60. PubMed ID: 7940934
    [No Abstract]   [Full Text] [Related]  

  • 9. Sandimmun neoral improves the bioavailability of cyclosporin A and decreases inter-individual variations in patients affected with cystic fibrosis.
    Girault D; Haloun A; Viard L; Bellon G; Gottrand F; Guillemain R; Lenoir G; Ladurie FL; Plouvier E; Storni V
    Transplant Proc; 1995 Aug; 27(4):2488-90. PubMed ID: 7652899
    [No Abstract]   [Full Text] [Related]  

  • 10. Decreased cyclosporine absorption after treatment with GoLytely lavage solution in a kidney transplant patient.
    Santa T; Nishihara K; Horie S; Kotaki H; Yamamoto K; Shibuya F; Ito K; Sawada Y; Kawabe K; Iga T
    Ann Pharmacother; 1994; 28(7-8):963-4. PubMed ID: 7949524
    [No Abstract]   [Full Text] [Related]  

  • 11. [Variability of the bioavailability of cyclosporine: benefit of the Neoral formulation].
    Humbert H
    Therapie; 1997; 52(4):353-7. PubMed ID: 9437891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the oral absorption of cyclosporin in man.
    Drewe J; Meier R; Vonderscher J; Kiss D; Posanski U; Kissel T; Gyr K
    Br J Clin Pharmacol; 1992 Jul; 34(1):60-4. PubMed ID: 1633069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Conversion from Consupren sol. to Consupren S capsules in kidney transplant patients].
    Matl I; Vítko S; Bubenícek P; Horcicková M; Lácha J; Lánská V; Marecková O; Nosková L; Petrásek R; Reneltová I; Táborský P
    Vnitr Lek; 1999 Mar; 45(3):167-9. PubMed ID: 15641241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced absorption of new oral cyclosporin microemulsion formulation, Neoral, in liver transplant recipients with external biliary diversion.
    Trull AK; Tan KK; Tan L; Alexander GJ; Jamieson NV
    Transplant Proc; 1994 Oct; 26(5):2977-8. PubMed ID: 7940939
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of oral cyclosporine A in stable kidney transplant recipients: a critical review.
    Foradori AC; Martínez L; Elberg A; Vacarezza A; Loveluck A; Pinto C
    Transplant Proc; 1995 Apr; 27(2):1815-6. PubMed ID: 7725516
    [No Abstract]   [Full Text] [Related]  

  • 16. Blood cyclosporin A and metabolite kinetic profiles after administration of Sandimmune soft gelatine capsules and Neoral in transplant recipients.
    Vernillet L; Kovarik JM; Freiburghaus R; Schaub P; Mueller EA; Niederberger W; Zehender H
    Transplant Proc; 1994 Oct; 26(5):2964-8. PubMed ID: 7940936
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bioequivalence research of cyclosporin soft capsules].
    Wu Y; Mao M; Wang L; Jiang X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Apr; 29(2):311-4, 331. PubMed ID: 22616181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative bioavailability of a new oral form of cyclosporin A in patients with rheumatoid arthritis.
    van den Borne BE; Landewé RB; Goei The HS; Mattie H; Breedveld FC; Dijkmans BA
    Br J Clin Pharmacol; 1995 Feb; 39(2):172-5. PubMed ID: 7742156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation of cyclosporin G in comparison to cyclosporine.
    Mangold JB; Schran HF; Yatscoff RW; Weitzel WF; Leichtman AB
    Transplant Proc; 1994 Oct; 26(5):3013-6. PubMed ID: 7940950
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic conversion study of a new cyclosporine formulation in stable adult renal transplant recipients.
    Perlík F; Masri MA; Rost M; Kamarád V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):309-13. PubMed ID: 16601778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.